Intranasal vaccination with pneumococcal surface protein A and Interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection

B. P. Arulanandam, J. M. Lynch, D. E. Briles, S. Hollingshead, D. W. Metzger

Research output: Contribution to journalArticlepeer-review

121 Scopus citations

Abstract

Streptococcus pneumoniae is a major pathogen in humans that enters the host primarily through the respiratory tract. Targeting mucosal surfaces directly may therefore be an optimal approach for vaccination to prevent bacterial colonization and invasive disease. We have previously demonstrated the effectiveness of interleukin-12 (IL-12) delivered intransally (i.n.) as an antiviral respiratory adjuvant. In this study, we examined the effects of i.n. IL-12 treatment on induction of protective humoral immunity against S. pneumoniae. Immunization i.n. with pneumococcal surface protein A (PspA) and IL-12 resulted in enhanced lung IL-10 mRNA expression and marked augmentation of respiratory and systemic immunoglobulin G1 (IgG1), IgG2a, and IgA antibody levels compared to those in animals receiving PspA alone. In addition, i.n. vaccination with PspA and IL-12 provided increased protection against nasopharyngeal carriage. Flow cytometric analysis revealed a threefold increase in antibody mediated, complement-independent opsonic activity in the sera of PspA- and IL-12-treated animals, which was mainly contributed by IgG2a and, to a lesser extent, IgA. Passive transfer of these immune sera conferred complete protection from death upon systemic pneumococcal challenge. These findings demonstrate the effectiveness of combining PspA and IL-12 at mucosal sites to achieve optimal antibody-mediated opsonization and killing of S. pneumoniae.

Original languageEnglish (US)
Pages (from-to)6718-6724
Number of pages7
JournalInfection and immunity
Volume69
Issue number11
DOIs
StatePublished - 2001
Externally publishedYes

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Intranasal vaccination with pneumococcal surface protein A and Interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection'. Together they form a unique fingerprint.

Cite this